LINDSEY DUNCAN: Open Payments
NPI 1821481474 · BRIDGETON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 98 payments from 19 companies in 2025. Trend: 2023 $1,061 · 2024 $1,323 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $297 |
| PFIZER INC. | 13 | $209 |
| Lilly USA, LLC | 10 | $201 |
| Novo Nordisk Inc | 11 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $151 |
| AstraZeneca Pharmaceuticals LP | 6 | $113 |
| Amgen Inc. | 4 | $88 |
| Axsome Therapeutics, Inc. | 5 | $82 |
| SANOFI-AVENTIS U.S. LLC | 2 | $67 |
| Exact Sciences Corporation | 3 | $65 |
Products named: MOUNJARO, CAPLYTA, NURTEC ODT, VRAYLAR, QULIPTA, UBRELVY, Ozempic, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
